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Background: The literature on diagnostic tests for food allergy currently lacks clear consensus regarding the
accuracy and safety of different investigative approaches. The European Academy of Allergy and Clinical
Immunology is in the process of developing its Guideline for Food Allergy and Anaphylaxis, and this systematic
review is one of seven inter-linked evidence syntheses that are being undertaken in order to provide a state-of-the-art
synopsis of the current evidence base in relation to epidemiology, prevention, diagnosis and clinical management, and
impact on quality of life, which will be used to inform the formulation of clinical recommendations. The aim of this
systematic review will be to assess the diagnostic accuracy of tests aimed at supporting the clinical diagnosis of
IgE-mediated food allergy.
Methods: The following databases from inception to September 30, 2012 will be searched for studies of diagnostic
tests: Cochrane Library (Wiley&Sons); MEDLINE (OVID); Embase (OVID); CINAHL (Ebscohost); ISI Web of Science
(Thomson Web of Knowledge); TRIP Database (web www.tripdatabase.com); and Clinicaltrials.gov (NIH web). These
database searches will be supplemented by contacting an international panel of experts. Studies evaluating APT, SPT,
specific-IgE, and component specific-IgE in participants of any age with suspected food allergy will be included. The
reference standard will be DBPCFC in at least 50% of the participants. Studies will be quality assessed by using the
QUADAS-2 instrument. We will report summary statistics such as sensitivity, specificity, and/or likelihood ratios. We will
use the hierarchical summary ROC (HSROC) model to summarize the accuracy of each test and to compare the
accuracy of two or more tests.
Discussion: Decisions on which tests to use need to be guided by availability of tests, populations being cared for,
risks, financial considerations and test properties. This review will examine papers from around the world, covering
children and adults with suspected food allergy in varying populations and concentrated on four type of tests: APT,
SPT, specific-IgEs, and component specific-IgEs.
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The umbrella term ‘food hypersensitivity’ can be used to
describe any ‘adverse reaction to food’ [1]. The term
‘food allergy’ refers to the subgroup of food-triggered re-
actions in which immunologic mechanisms have been
implicated, whether IgE-mediated, non-IgE-mediated, or
involving a combination of IgE- and non-IgE-mediated* Correspondence: aziz.sheikh@ed.ac.uk
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distribution, and reproduction in any mediumetiologies [2]. All other reactions to food that were in
the past sometimes referred to as ‘food intolerance’ con-
stitute non-allergic food hypersensitivity reactions and
are out of the focus of this enquiry. Coeliac disease is an
important non-IgE mediated condition but as it has dis-
tinct symptoms and prognosis different from atopic con-
ditions it will be excluded from this review [3].
Allergic sensitisation to a specific food does not always
lead to clinical reactions. Consequently, serological tests
for food-specific IgE or the determination of positive
skin prick test results are in of themselves insufficient toentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ther, there must also be evidence of the clinical expres-
sion of disease. These IgE-mediated reactions can have a
number of clinical expressions, including angioedema,
urticaria, atopic eczema/dermatitis, oral allergy syn-
drome and anaphylaxis. Non-IgE-mediated immunologic
reactions result from activation of other immunologic
pathways (e.g. T-cell mediated) and can manifest as
atopic eczema/dermatitis, gastro-esophageal reflux dis-
ease, food protein-induced enterocolitis, proctocolitis,
and enteropathy syndromes. The contemporary defin-
ition of food allergy thus includes several clinical entities
with different pathophysiologies (see Table 1 below)
resulting from exposure to different foods [3].
The first and most important step in the diagnosis of
food allergy involves a full clinical history and clinical
examination. Numerous diagnostic tests have been pro-
posed as useful adjuncts in those with a suggestive clin-
ical history. The most commonly studied are skin prick
testing (SPT), serum food-specific IgE determinations
and atopy patch testing (APT), although APT is not in
widespread clinical use. The double-blind placebo con-
trolled food challenge (DBPCFC) is usually considered
the gold standard diagnostic test. Food challenge tests
are however time-consuming and resource-intensive,
particularly if undertaken in a double-blind manner.
Other tests that have been investigated for diagnosing
food allergy include histamine, tryptase and chymase
assays [2].
The literature on diagnostic tests for food allergy cur-
rently lacks clear consensus regarding the accuracy andTable 1 Pathologies with respective disorders seen in
food allergy
Pathology Disorder
IgE-mediated
(acute-onset)
• Acute urticaria (weals, angioedema or both)
• Contact urticaria
• Atopic eczema/dermatitis
• Anaphylaxis
• Food-associated, exercise-induced anaphylaxis
• Oral allergy syndrome
(pollen-associated food allergy syndrome)
• Immediate gastrointestinal hypersensitivity
Cell-mediated
(delayed onset/chronic)
• Atopic eczema/dermatitis
• Food protein-induced enterocolitis syndrome
• Food protein-induced allergic proctocolitis
• Allergic contact dermatitis
• Heiner syndrome
Combined IgE
and cell-mediated
(delayed onset/chronic)
• Atopic eczema/dermatitis
• Eosinophilic oesophagitis
• Eosinophilic gastroenteritissafety of different investigative approaches. The European
Academy of Allergy and Clinical Immunology (EAACI) is
in the process of developing the EAACI Guideline for Food
Allergy and Anaphylaxis, and this systematic review is
one of seven inter-linked evidence syntheses that are being
undertaken in order to provide a state-of-the-art synopsis
of the current evidence base in relation to epidemiology,
prevention, diagnosis and clinical management, and im-
pact on quality of life, which will be used to inform the
formulation of clinical recommendations.
Aims
The aim of this systematic review will be to assess the
diagnostic accuracy of tests aimed at supporting the
clinical diagnosis of IgE-mediated food allergy.
Methods
Search strategy
A highly sensitive search strategy has been developed
and validated study design filters will be applied to re-
trieve all articles pertaining to the diagnosis of food al-
lergy from electronic bibliographic databases. We have
conceptualised the search to incorporate three elements
as shown in Figure 1: Conceptualisation of systematic
review of diagnostic tests for food allergy.
To retrieve diagnostic studies, we will use the diagno-
sis filter developed at McMaster University Health Infor-
mation Research Unit (HIRU) [4].
We will search the following databases:
 Cochrane Library, including:
○ Cochrane Database of Systematic Reviews
(CDSR)
○ Database of Reviews of Effectiveness (DARE)
○ CENTRAL (Trials)
○ Methods Studies
○ Health Technology Assessments (HTA)
○ Economic Evaluations Database (EED)
 MEDLINE (OVID)
 Embase (OVID)
 CINAHL (Ebscohost)
 ISI Web of Science (Thomson Web of Knowledge)
 TRIP Database (www.tripdatabase.com)
 Clinicaltrials.gov (NIH web)
The search strategy has been devised on OVID
MEDLINE and then adapted for the other databases (see
Additional file 1: for full search strategies). In all cases,
the databases will be searched from inception to 30 Sep-
tember 2012. All references will be imported into an
EndNote Library and tagged with the name of the data-
base. Additional references will be located through
searching the references cited by the identified studies,
and unpublished work and research in progress will be
• Systematic reviews
• Prospective, including 
cross-sectional studies
• Retrospective, including 
case-control studies
Study designs
• Any age (-presenting with 
suspected food allergy)
Participants
• Atopy patch tests
• Skin prick tests
• Specific IgEs
• Component specific-IgEs
Index tests
• DBPCFC in at least 
50% of the included 
participants
Reference 
Standard
Figure 1 Conceptualisation of systematic review of diagnostic tests for food allergy.
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We will invite experts who are active in the field from a
range of disciplines and locations to comment on our
search strategy and the list of included studies. There
are no language restrictions and, where possible, all lit-
erature will be translated.
Inclusion criteria
 Study design:
○ The studies of diagnostic tests must have
sufficient data to calculate sensitivity, specificity,
and negative and positive predictive values.
○ Studies with prospective, cross-sectional or
retrospective design will be included. The
studies must have a defined study population,
and specify the recruitment method, either
consecutive or random sampling of participants.
Where the recruitment method is not clearly
reported, we will include such studies and assess
their influence on test performance through
undertaking sensitivity analyses.
 Types of participants:
○ Any age (children and adults) presenting
with suspected food allergy.
 Target conditions:
○ Studies examining the diagnostic accuracy of
tests for IgE-mediated food allergies (see Table 1),
against any type of food will be included.
 Index tests: We will document the tests that have
been studied, but will focus in our analysis on:
○ For IgE-mediated food allergy:
▪ APT
▪ SPT
▪ Specific-IgE
▪ Component specific-IgE Reference standard:
○ The reference standard will be the DBPCFC,
which is considered the gold standard for
diagnosing food allergy. Where studies used
either theDBPCFC or an open food challenge
(OFC), these will be included if more than
50% of the participants received DBPCFC.Exclusion criteria
 Study design:
○ Reviews, discussion papers, non-research letters
and editorials
○ Qualitative studies
○ Case studies, case series
○ Animal studies
 Types of participants:
○ Studies will be excluded if the patients were
selected based on having a positive food allergy
test result (index test or reference standard).
 Analysis:
○ We will conduct a per patient analyses, hence
the studies will be excluded if only per
challenge results are reported.Study selection
The titles will be checked independently by two re-
viewers according to the above selection criteria and
categorised as: included, excluded or unsure. For those
papers in the unsure category, we will retrieve the ab-
stract and re-evaluate using the same categorisation.
Any discrepancies will be resolved by consensus and, if
necessary, a third reviewer will be consulted. Full text
copies of potentially relevant studies will be obtained
and their eligibility for inclusion will be independently
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criteria will be excluded.
Data extraction and management
Data will be independently extracted onto a customised
form by two reviewers, and any discrepancies will be re-
solved by discussion or, if agreement cannot be reached,
by arbitration by a third reviewer.
Study characteristics will be collected and the number
of true positives (TP), true negatives (TN), false positives
(FP), and false negatives (FN) will be recorded for
constructing a 2x2 table for each study. If the 2x2 data
are not available, attempts will be made to derive them
from reported summary statistics such as sensitivity, spe-
cificity and/or likelihood ratios.
Quality assessment strategy
Quality assessments will be performed using the
QUADAS-2 tool [5]. Each study will be independently
assessed by two reviewers. Any discrepancies will be re-
solved by discussion or, if agreement cannot be reached,
by arbitration by a third reviewer.
We will assess the quality of evidence for diagnosis,
rating the evidence for each test as:
 High: Further research is very unlikely to change
our confidence in the estimates of test performance.
 Moderate: Further research is likely to have an
important impact on our confidence in the estimates
of test performance and may change the estimates.
 Low: Further research is very likely to have an
important impact on our confidence in the estimates
of test performance and is likely to change the
estimates.
Data analysis and synthesis
We will examine test accuracy according to food allergy
type, food allergen studied and food allergy test type.
Preliminary exploratory analyses will be conducted for
each test by plotting estimates of sensitivity and specifi-
city from each study on forest plots and in receiver oper-
ating characteristic (ROC) space. These analyses will
enable visual assessment of the variation between studies,
and will also facilitate subgroup analyses for exploring the
effect of certain characteristics on test performance.
Because we anticipate that the cut-offs used to define
test positivity may vary between studies of some tests,
where appropriate, we will use the hierarchical summary
ROC (HSROC) model [6,7] to summarise the accuracy
of each test and to compare the accuracy of two or more
tests. The HSROC model accounts for within study vari-
ability, and unexplained differences between studies
through the inclusion of random effects. The model uses
study-specific estimates of the true positive rate(sensitivity) and the false positive rate (1 - specificity) to
estimate a SROC curve. If all the parameters of the
HSROC model cannot be reliably estimated due to a
limited number of studies, we will simplify the model by
assuming a symmetrical shape for the curve. Where
studies have used a common or similar cut-off, we will
use parameter estimates from the models to compute
summary sensitivities and specificities with 95% confi-
dence regions.
For making comparisons between tests, we will ini-
tially include all studies in the analysis (indirect com-
parison). Subsequently, if data are available, we will
restrict the analyses to only studies that have compared
tests in the same population, either within patients or
between randomised groups (direct comparison). Such
analyses are likely to produce results not confounded by
differences in study or patient characteristics.
To investigate heterogeneity, the following covariates
will be added to the HSROC model to assess the associ-
ation of study and patient characteristics with test per-
formance: country, different cut-offs for the index test
and whether all participants received the reference
standard. Sensitivity analyses will be used to explore the
effect of potentially influential studies and study quality.
Preliminary analyses will be done using RevewManager
5.2 (The Nordic Cochrane Centre, The Cochrane Col-
laboration, 2012), and the HSROC model will be fitted
using the NLMIXED procedure in the SAS software
(version 9.2; SAS Institute, Cary, NC). We will calculate
summary ROC curves by transforming sensitivity and
specificity pairs (weighted by sample size) using logistic
transforms and regressing logit sensitivities on logit
specificities. Summary ROC curves will be calculated by
back transforming predicted values from these regres-
sion models. We will calculate the 95% confidence inter-
val (CI) for the summary ROC curves by re-estimating
the curves on bootstrap samples.These analyses will be
performed with Stata version 10.0 (StataCorp LP, College
Station, Texas). A narrative synthesis of the data will also
be undertaken.
Reporting
This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
and has the registration number CRD42013003707 allo-
cated to it. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist will be
used to guide the reporting of the systematic review [8].
Discussion
Our review will concentrate on four type of tests: APT,
SPT, specific-IgEs, and component specific-IgEs. The de-
cision on which tests to use in clinical practice need to
be made on a range of considerations, these including
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relative safety, costs and diagnostic properties. The focus
of this review will very much been on the latter
consideration.
Additional file
Additional file 1: Search strategies.
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